Estabrook Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$443 Hold
74
﹤0.01% 372
2025
Q4
$531 Hold
74
﹤0.01% 319
2025
Q3
$790 Hold
74
﹤0.01% 317
2025
Q2
$716 Sell
74
-30
-29% -$309 ﹤0.01% 318
2025
Q1
$1.55K Hold
104
﹤0.01% 309
2024
Q4
$1.55K Hold
104
﹤0.01% 324
2024
Q3
$1.99K Sell
104
-22
-17% -$456 ﹤0.01% 330
2024
Q2
$2.61K Sell
126
-46
-27% -$914 ﹤0.01% 320
2024
Q1
$3.23K Hold
172
﹤0.01% 325
2023
Q4
$2.48K Hold
172
﹤0.01% 336
2023
Q3
$2.99K Hold
172
﹤0.01% 333
2023
Q2
$3.58K Sell
172
-440
-72% -$9.56K ﹤0.01% 338
2023
Q1
$14.4K Sell
612
-48
-7% -$1.29K ﹤0.01% 287
2022
Q4
$18.4K Sell
660
-127
-16% -$3.25K ﹤0.01% 273
2022
Q3
$18.4K Sell
787
-400
-34% -$12.1K ﹤0.01% 269
2022
Q2
$40.1K Sell
1,187
-35
-3% -$1.23K 0.01% 228
2022
Q1
$42.7K Sell
1,222
-12
-1% -$410 0.01% 232
2021
Q4
$37.6K Sell
1,234
-719
-37% -$23.4K 0.01% 249
2021
Q3
$64K Sell
1,953
-5,351
-73% -$171K 0.01% 180
2021
Q2
$221K Buy
+7,304
New +$240K 0.03% 133

Other funds holding OGN

Estabrook Capital Management's OGN Position: Q1 2026 in Review

Estabrook Capital Management held its Organon & Co (OGN) position steady in Q1 2026 at 74 shares worth $443. The position accounts for ﹤0.01% of the portfolio, ranked #372.

Estabrook Capital Management first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $221K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Estabrook Capital Management held 74 shares of Organon & Co worth $443 as of Q1 2026.
  • Estabrook Capital Management left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Estabrook Capital Management's portfolio in Q1 2026, its #372 holding.
  • Estabrook Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Estabrook Capital Management's Organon & Co position peaked at $221K in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.